Abeona Therapeutics Inc. · NASDAQ:ABEO
Vasanthavada Madhav sold 9,620 Abeona Therapeutics Inc. shares (Form 4)
Traded Jun 8 to Jun 9, 2026 · Filed Jun 9, 2026
From Jun 8 to Jun 9, 2026, Vasanthavada Madhav (Chief Commercial Officer) sold 9,620 Abeona Therapeutics Inc. shares at an average US$5.36 for US$51,528, leaving 303,451 shares. Filed Jun 9, 2026 (Form 4).
- Sold
- 9,620 shares
- Price
- US$5.36 average (US$5.30 to US$5.43)
- Value
- US$51,528
- Holding after
- 303,451 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | Sale | 4,170 | US$5.43 | 308,901 | Direct |
| Jun 9, 2026 | Common Stock | Sale | 5,450 | US$5.30 | 303,451 | Direct |
Source
Related
- Abeona Therapeutics Inc.
- Vasanthavada Madhav
- Abeona Therapeutics Inc. shareholders
- Form 4 · Vasanthavada Madhav · Sep 29, 2026
- Form 4 · Vasanthavada Madhav · Jul 9, 2026
- Form 4 · Vasanthavada Madhav · Jun 17, 2026
- Form 4 · Vasanthavada Madhav · May 11, 2026
- Form 4 · Seshadri Vishwas · Sep 29, 2026
- Form 4 · Vazzano Joseph Walter · Sep 29, 2026
- Form 4 · O'Malley Brendan M. · Sep 29, 2026
- Form 4 · Alvino Mark · Sep 1, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026